Phosphate study for people with kidney disease
Part of Bones, joints & muscles, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how the body handles phosphate in people with chronic kidney disease. It may help researchers understand how to better manage phosphate levels to improve health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have chronic kidney disease at stage 3 or 4 (moderate to severe), or you have healthy kidneys but no protein in your urine
- You do not smoke or use nicotine products
- You are not on dialysis or have a kidney transplant
- You are not pregnant, breastfeeding, or less than 3 months after giving birth
- You can speak and read English and are willing to eat the study meals and follow the diet
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether regulating parathyroid hormone (PTH) can improve bone density in people with advanced chronic kidney disease (CKD) who are not on dialysis. It may help you if you have stage 4-5 CKD and high PTH levels.
This study looks at how eating different amounts of phosphorus affects your bones and blood calcium and phosphorus. It may help find better dietary recommendations for people with moderate chronic kidney disease.
This study looks at how your body handles extra phosphate (a mineral found in many foods) and whether age or sex changes that response. Researchers will give healthy volunteers more phosphate and measure blood and urine levels to understand the effect.
This trial compares two treatment goals for blood phosphate levels in people with end-stage kidney disease who are on dialysis. It may help determine which target is safer and works better in real-world care.
This early study looks at how the body’s handling of phosphate may affect aging and bone health. It is meant for people with certain rare genetic conditions that change phosphate levels, to better understand their biology and responses to study tests.
This study looks at how giving phosphate supplements affects a hormone called FGF23 in patients with low blood phosphate levels. It aims to help understand how the body responds to treatment.
Hear when a new Chronic Kidney Disease (Stage 3-4) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.